跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FL-3
首页
药物
FL-3
FL-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A NUTRITIONAL COMPOSITION COMPRISING A COMBINATION OF HUMAN MILK OLIGOSACCHARIDES TO IMPROVE THE GASTROINTESTINAL BARRIER
US 2022062311 A1
申请人: NESTLE SA
优先权: 2018
CN
EP
US
WO
11 件公开
MIXTURE OF HMOS
EP 3389668 A4
申请人: GLYCOM AS
优先权: 2015
CN
EP
US
7 件公开
MIXTURE OF HMOS AND BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISM
EP 4784146 A1
申请人: NESTLE SA
优先权: 2023
CN
EP
WO
6 件公开
WO 2025201672 A1
申请人: NESTLE SA
优先权: 2024
WO
AGENTS, COMPOSITIONS, AND METHODS FOR SUPPORTING BEHAVIOURAL DEVELOPMENT
EP 4658095 A1
申请人: NESTLE SA
优先权: 2023
CN
EP
US
WO
4 件公开
NUTRIENT COMPOSITION, FOOD INCLUDING THE SAME AND USE OF THE NUTRIENT COMPOSITION
US 2023181608 A1
申请人: HEILONGJIANG FEIHE DAIRY CO LTD
优先权: 2021
CN
EP
US
3 件公开
COMBINATION FOR DIETARY MANAGEMENT OF GUT HEALTH
EP 4739149 A1
申请人: NESTLE SA
优先权: 2023
CN
EP
WO
3 件公开
3-FUCOSYLLACTOSE AND BUTYRATE FOR FOOD ALLERGY
EP 4783881 A1
申请人: NUTRICIA NV
优先权: 2023
CN
EP
WO
3 件公开
USE OF 2'-FUCOSYLLACTOSE OR 3'-SIALYLLACTOSE FOR REDUCING THE GROWTH OF MICROBES
EP 4798309 A1
申请人: DSM IP ASSETS BV
优先权: 2023
CN
EP
WO
3 件公开
Synthetic composition and method for treating irritable bowel syndrome
US 11833165 B2
申请人: GLYCOM AS
优先权: 2014
CN
US
3 件公开
CRYSTAL OF COMPOUND AS C-MET KINASE INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 3766870 A4
申请人: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
优先权: 2018
CN
EP
3 件公开
第 1 / 8 页
上一页
下一页
药物
反馈